Innovent Biopharmaceutical Transformation slide image

Innovent Biopharmaceutical Transformation

Innovent 2021 Annual Results Investor Presentation March, 2022 Innovent To develop and commercialize high quality biopharmaceuticals that are affordable to ordinary people.
View entire presentation